Literature DB >> 17048876

Amyloid fibril formation and other aggregate species formed by human serum albumin association.

Pablo Taboada, Silvia Barbosa, Emilio Castro, Víctor Mosquera.   

Abstract

Under in vitro solution conditions where the native state is destabilized, many proteins present an abnormal structure and metabolism associated with a strong tendency to self-aggregation into a polymeric amyloid fibril structure, suggesting that this ability is a generic feature of the polypeptide chains. Such structures play a key role in different pathogenesis of neurodegenerative diseases such as Alzheimer, Parkinson, or Creutzfeldt-Jakob. Here, we report the formation of amyloid fibrils in the plasma protein human serum albumin under different in vitro conditions monitored using a combination of spectrophotometric and microscopic techniques. Amyloid fibril formation, therefore, is also allowed in a protein with a high degree of structural complexity. We also infer from experimental data the existence of other protein aggregated species than fibrils, some of which seem to be formed by a structural rearrangement of the proper fibrils.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048876     DOI: 10.1021/jp064861r

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  16 in total

1.  Thermal aggregation of bovine serum albumin at different pH: comparison with human serum albumin.

Authors:  Valeria Vetri; Fabio Librizzi; Maurizio Leone; Valeria Militello
Journal:  Eur Biophys J       Date:  2007-07-12       Impact factor: 1.733

2.  Ovalbumin self-assembles into amyloid nanosheets that elicit immune responses and facilitate sustained drug release.

Authors:  Saba Tufail; Mohd Asif Sherwani; Shoaib Shoaib; Sarfuddin Azmi; Mohammad Owais; Najmul Islam
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

3.  Amyloid form of ovalbumin evokes native antigen-specific immune response in the host: prospective immuno-prophylactic potential.

Authors:  Saba Tufail; Mohammad Owais; Shadab Kazmi; Renu Balyan; Jasneet Kaur Khalsa; Syed Mohd Faisal; Mohd Asif Sherwani; Manzoor Ahmad Gatoo; Mohd Saad Umar; Swaleha Zubair
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

4.  Bovine serum albumin oligomers in the E- and B-forms at low protein concentration and ionic strength.

Authors:  Jeremiah J Babcock; Lorenzo Brancaleon
Journal:  Int J Biol Macromol       Date:  2012-11-10       Impact factor: 6.953

5.  Existence of different structural intermediates on the fibrillation pathway of human serum albumin.

Authors:  Josué Juárez; Pablo Taboada; Víctor Mosquera
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

6.  Fluorescent filter-trap assay for amyloid fibril formation kinetics in complex solutions.

Authors:  Irem Nasir; Sara Linse; Celia Cabaleiro-Lago
Journal:  ACS Chem Neurosci       Date:  2015-05-20       Impact factor: 4.418

7.  Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight.

Authors:  Sumit Kumar Chaturvedi; Nida Zaidi; Parvez Alam; Javed Masood Khan; Atiyatul Qadeer; Ibrar Ahmad Siddique; Shamoon Asmat; Yusra Zaidi; Rizwan Hasan Khan
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

8.  Oxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formation.

Authors:  Giuseppe Sancataldo; Valeria Vetri; Vito Foderà; Gianluca Di Cara; Valeria Militello; Maurizio Leone
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Albumin fibrillization induces apoptosis via integrin/FAK/Akt pathway.

Authors:  Chun-Yung Huang; Chi-Ming Liang; Chiao-Li Chu; Shu-Mei Liang
Journal:  BMC Biotechnol       Date:  2009-01-08       Impact factor: 2.563

Review 10.  Extrinsic fluorescent dyes as tools for protein characterization.

Authors:  Andrea Hawe; Marc Sutter; Wim Jiskoot
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.